Explore our corporate updates and press releases below. For the latest news, follow us on LinkedIn.
To learn more about our company, visit our Corporate Overview page. To see our progress toward new answers and disease-centric therapies, visit our Pipeline page or review recent articles and studies on our Publications page.
|06/26/2020||June 2020 Update||Corporate Update|
|05/05/2020||Ichnos Sciences appoints David Lubner to Board of Directors||Press Release|
|02/21/2020||February 2020 update||Corporate Update|
|02/05/2020||Ichnos expands leadership team with appointment of Gabriela Gruia, M.D. as Chief Development Officer||Press Release|
|12/04/2019||Ichnos Sciences expands leadership team with key appointments||Press Release|
|11/24/2019||Ichnos Sciences strengthens board with addition of Marcela Maus, MD, PHD||Press Release|
|11/12/2019||November 2019 update||Corporate Update|
|11/04/2019||Ichnos Sciences announces completion of enrollment of phase 2B trials for two investigational therapies – ISB 830 and ISC 27864||Press Release|
|10/15/2019||Ichnos Sciences launches as new, independent, leading-edge biotech Dedicated to Outpacing Disease||Press Release|
|10/15/2019||Watch our launch video||Press Release|
The link above is provided for your convenience, and Ichnos is not responsible for content, privacy, or security issues associated with your visit to external websites.